Literature DB >> 18360066

Prognostic implications of left ventricular wall motion abnormalities associated with subarachnoid hemorrhage.

Keiko Sugimoto1, Eiichi Watanabe, Akira Yamada, Masatsugu Iwase, Hirotoshi Sano, Hitoshi Hishida, Yukio Ozaki.   

Abstract

Left ventricular (LV) dysfunction generally occurs early in the course of subarachnoid hemorrhage (SAH). We evaluated the prognostic value of electrocardiographic (ECG) abnormalities and echocardiographic LV dysfunction evaluated shortly after SAH. We prospectively enrolled 47 SAH patients (62 +/- 14 years, mean +/- SD) who were admitted to the neurosurgical care unit of our institute. Neurological status was rated on the day of admission. Twelve-lead ECG and 2-dimensional echocardiography were recorded 2 +/- 1 day after onset of SAH. ECG abnormalities (pathological Q-wave, ST-segment deviation, T-wave inversion, and QT prolongation) were evaluated and the incidences of global (LV ejection fraction < 50%) and segmental (regional wall motion abnormality [RWMA]) LV dysfunction were measured. During a follow-up period of 44 +/- 23 days, 17 (36%) patients died. ECG abnormalities, LV ejection fraction < 50%, and RWMA were observed in 62%, 11%, and 28% of patients, respectively. Univariate Cox proportional hazards regression analysis revealed that neurological status, rate-corrected QT interval, LV ejection fraction, and RWMA were significant predictors of death. After adjustment for these significant clinical variables, and age and sex, independent predictors of mortality were neurological status and RWMA. RWMA may provide significant prognostic information in patients with SAH.

Entities:  

Mesh:

Year:  2008        PMID: 18360066     DOI: 10.1536/ihj.49.75

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  18 in total

1.  High-Sensitive Troponin T and N-Terminal Pro B-Type Natriuretic Peptide for Early Detection of Stress-Induced Cardiomyopathy in Patients with Subarachnoid Hemorrhage.

Authors:  J Oras; C Grivans; K Dalla; E Omerovic; B Rydenhag; S-E Ricksten; H Seeman-Lodding
Journal:  Neurocrit Care       Date:  2015-10       Impact factor: 3.210

2.  Automatic classification of left ventricular regional wall motion abnormalities in echocardiography images using nonrigid image registration.

Authors:  Ahmad Shalbaf; Hamid Behnam; Zahra Alizade-Sani; Maryam Shojaifard
Journal:  J Digit Imaging       Date:  2013-10       Impact factor: 4.056

Review 3.  Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage.

Authors:  Nicolas Bruder; Alejandro Rabinstein
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 4.  [Tako-Tsubo cardiomyopathy].

Authors:  J Roggenbach; R Roggenbach; P Ehlermann
Journal:  Anaesthesist       Date:  2010-07       Impact factor: 1.041

Review 5.  Cardiovascular protection to improve clinical outcomes after subarachnoid hemorrhage: is there a proven role?

Authors:  Toshimasa Okabe; Mitul Kanzaria; Fred Rincon; Walter K Kraft
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

Review 6.  Impact of echocardiographic wall motion abnormality and cardiac biomarker elevation on outcome after subarachnoid hemorrhage: a meta-analysis.

Authors:  Limin Zhang; Bing Zhang; Sihua Qi
Journal:  Neurosurg Rev       Date:  2018-05-26       Impact factor: 3.042

7.  Association between elevated plasma norepinephrine levels and cardiac wall motion abnormality in poor-grade subarachnoid hemorrhage patients.

Authors:  Keiko Sugimoto; Joji Inamasu; Yoko Kato; Yasuhiro Yamada; Tsukasa Ganaha; Motoki Oheda; Natsuki Hattori; Eiichi Watanabe; Yukio Ozaki; Yuichi Hirose
Journal:  Neurosurg Rev       Date:  2012-08-31       Impact factor: 3.042

8.  Elevated cardiac troponin I and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage.

Authors:  Marilyn Hravnak; J Michael Frangiskakis; Elizabeth A Crago; Yuefang Chang; Masaki Tanabe; John Gorcsan; Michael B Horowitz
Journal:  Stroke       Date:  2009-08-27       Impact factor: 7.914

Review 9.  Management of aneurysmal subarachnoid hemorrhage.

Authors:  Michael N Diringer
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

10.  Long-Term Outcomes for Different Forms of Stress Cardiomyopathy After Surgical Treatment for Subarachnoid Hemorrhage.

Authors:  Azra Bihorac; Tezcan Ozrazgat-Baslanti; Elizabeth Mahanna; Seemab Malik; Peggy White; Matthew Sorensen; Brenda G Fahy; John W Petersen
Journal:  Anesth Analg       Date:  2016-05       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.